Medical trial workflow platform OneStudyTeam, a Reify Well being firm, introduced its partnership with Antidote Applied sciences, a digital affected person engagement firm, to offer an end-to-end scientific trial recruitment platform.
OneStudyTeam’s cloud-based software program StudyTeam connects research websites and sponsors to help in recruiting, prescreening and enrolling sufferers in scientific trials.
Antidote’s affected person engagement platform connects sponsors and sufferers. It is now built-in with StudyTeam’s Referral Companion Interface.
“The place OneStudyTeam offers visibility to measure and perceive gaps in enrollment technique, Antidote has mastered figuring out these essential sufferers and matching them to the best trial,” Ralph Passarella, CEO of OneStudyTeam, mentioned in a press release. “This collaboration spans the recruitment and enrollment continuum to drive variety, fairness, inclusion, and illustration amongst trial candidates.”
THE LARGER TREND
The Boston-based OneStudyTeam is an initiative of Reify Health, which gives scientific trial and infrastructure assist.
Antidote, based mostly within the U.S. and U.Okay., was launched as TrialReach greater than a decade in the past, then rebranded to Antidote in 2016.
Reify garnered $220 million in Series D funding in April, boosting the corporate’s valuation to $4.8 billion.
That spherical got here lower than a 12 months after the corporate raised $220 million in Series C funding. The corporate additionally introduced in $30 million in Series B financing in 2020.
